(Reuters) -(To receive the full newsletter in your inbox for free sign up here) Novo Nordisk’s diabetes medicine Rybelsus, an ...

Rybelsus comes as an oral tablet, while Ozempic comes as an injectable liquid solution. This article explains the main ways that Rybelsus and Ozempic are alike and different. For more information ...

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart ...

Rybelsus (semaglutide) is an oral medication used in combination with exercise and a healthy diet to help treat type 2 diabetes. It’s best taken on an empty stomach but isn’t known to interact ...

Novo Nordisk's Phase 3b STRIDE trial shows Ozempic improves walking distance in peripheral artery disease, while the SOUL trial finds Rybelsus lowers cardiovascular risk by 14%.

India's anti-obesity drug market has surged, growing over fourfold in five years, reaching ₹576 crore by March 2025, driven ...

There was also a 7% lower rate of cardiovascular death with Rybelsus. This level of risk reduction is in line with results from eight previous trials involving injectable GLP-1s, such as Novo's ...

Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial, paving the way for it to become a new treatment option for people living with ...